Literature DB >> 17351744

ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?

Teresa Tapia1, Alejandro Sanchez, Maricarmen Vallejos, Carolina Alvarez, Mauricio Moraga, Susan Smalley, Mauricio Camus, Manuel Alvarez, Pilar Carvallo.   

Abstract

Besides BRCA1 and BRCA2, two genes accounting for a small proportion of breast cancer cases, ATM has been widely proposed as a low-penetrance susceptibility gene. Several nucleotide changes have been proposed to be associated with breast cancer, still remaining a high controversy in this sense. We screened the ATM gene in 94 breast cancer patients selected from 78 high-risk families, not presenting a mutation in BRCA1 or BRCA2. We found three novel allelic variants: IVS64 + 51delT and p.L752L, not showing association with hereditary breast cancer, and p.L694L found in one family in two breast cancer patients. Two amino acid substitutions p.S707P and p.F858L, previously reported to be associated with breast cancer, were present in our study in cases and controls, lacking of association with breast cancer. A positive association of c.5557G>A (p.D1853N) was found (OR 2.52, P = 0.008), when analyzed alone and in combination with an intronic variant IVS24-9delT (OR 3.97; P = 0.0003). We postulate that our discrepancies with other reports related to the associated ATM alleles to hereditary breast cancer, as well as discrepancies in the literature between other groups, could be explained by the diversity in the ethnic origins of families gathered in a sole study, and the selection of the control group. In relation to this issue, and based on genetic markers, we found that the Chilean group of breast cancer families in this study has a stronger European genetic component than our control sample selected randomly from the Chilean population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351744     DOI: 10.1007/s10549-007-9544-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

1.  Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory.

Authors:  P Mehdipour; F Karami; Firouzeh Javan; M Mehrazin
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

2.  Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis.

Authors:  Chen Mao; Vincent C H Chung; Ben-Fu He; Rong-Cheng Luo; Jin-Ling Tang
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

3.  Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.

Authors:  Sean V Tavtigian; Peter J Oefner; Davit Babikyan; Anne Hartmann; Sue Healey; Florence Le Calvez-Kelm; Fabienne Lesueur; Graham B Byrnes; Shu-Chun Chuang; Nathalie Forey; Corinna Feuchtinger; Lydie Gioia; Janet Hall; Mia Hashibe; Barbara Herte; Sandrine McKay-Chopin; Alun Thomas; Maxime P Vallée; Catherine Voegele; Penelope M Webb; David C Whiteman; Suleeporn Sangrajrang; John L Hopper; Melissa C Southey; Irene L Andrulis; Esther M John; Georgia Chenevix-Trench
Journal:  Am J Hum Genet       Date:  2009-09-24       Impact factor: 11.025

4.  Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G.

Authors:  S Oliveira; J Ribeiro; H Sousa; D Pinto; I Baldaque; R Medeiros
Journal:  Oncol Rep       Date:  2011-12-22       Impact factor: 3.906

5.  The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis.

Authors:  Lin-Bo Gao; Xin-Min Pan; Hong Sun; Xia Wang; Li Rao; Li-Juan Li; Wei-Bo Liang; Mei-Li Lv; Wen-Zhong Yang; Lin Zhang
Journal:  J Exp Clin Cancer Res       Date:  2010-08-27

6.  A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies.

Authors:  Jing Guo; Mingjuan Jin; Mingwu Zhang; Kun Chen
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

7.  Functional polymorphisms in the CYP2C19 gene contribute to digestive system cancer risk: evidence from 11,042 subjects.

Authors:  Bo Zhou; Zhenshun Song; Mingping Qian; Liang Li; Jian Gong; Shaowu Zou
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

8.  A method for identifying discriminative isoform-specific peptides for clinical proteomics application.

Authors:  Fan Zhang; Jake Y Chen
Journal:  BMC Genomics       Date:  2016-08-22       Impact factor: 3.969

9.  Gene-environment interaction for polymorphisms in ataxia telangiectasia-mutated gene and radiation exposure in carcinogenesis: results from two literature-based meta-analyses of 27120 participants.

Authors:  Yuguang Zhao; Lei Yang; Di Wu; Hua He; Mengmeng Wang; Tingwen Ge; Yudi Liu; Huimin Tian; Jiuwei Cui; Lin Jia; Ziqiang Wan; Fujun Han
Journal:  Oncotarget       Date:  2016-11-22

10.  Association of common ATM variants with familial breast cancer in a South American population.

Authors:  Patricio González-Hormazábal; Teresa Bravo; Rafael Blanco; Carlos Y Valenzuela; Fernando Gómez; Enrique Waugh; Octavio Peralta; Waldo Ortuzar; Jose M Reyes; Lilian Jara
Journal:  BMC Cancer       Date:  2008-04-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.